Deutsche Bank’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-154,063
| Closed | -$632K | – | 4458 |
|
|
2022
Q1 | $632K | Sell |
154,063
-167,426
| -52% | -$607K | ﹤0.01% | 2618 |
|
|
2021
Q4 | $1.15M | Sell |
321,489
-149,930
| -32% | -$524K | ﹤0.01% | 2354 |
|
|
2021
Q3 | $1.72M | Sell |
471,419
-236,297
| -33% | -$955K | ﹤0.01% | 2217 |
|
|
2021
Q2 | $3.09M | Buy |
707,716
+176,027
| +33% | +$717K | ﹤0.01% | 1858 |
|
|
2021
Q1 | $2.19M | Buy |
531,689
+354,060
| +199% | +$1.53M | ﹤0.01% | 2114 |
|
|
2020
Q4 | $709K | Sell |
177,629
-26,452
| -13% | -$85.6K | ﹤0.01% | 2678 |
|
|
2020
Q3 | $551K | Buy |
204,081
+29,060
| +17% | +$80.4K | ﹤0.01% | 2585 |
|
|
2020
Q2 | $482K | Sell |
175,021
-88,902
| -34% | -$248K | ﹤0.01% | 2667 |
|
|
2020
Q1 | $623K | Sell |
263,923
-542,218
| -67% | -$1.84M | ﹤0.01% | 2367 |
|
|
2019
Q4 | $3.79M | Buy |
806,141
+719,695
| +833% | +$2.95M | ﹤0.01% | 1611 |
|
|
2019
Q3 | $286K | Sell |
86,446
-256,382
| -75% | -$844K | ﹤0.01% | 2975 |
|
|
2019
Q2 | $1.13M | Sell |
342,828
-684,653
| -67% | -$1.98M | ﹤0.01% | 2762 |
|
|
2019
Q1 | $3.11M | Buy |
1,027,481
+840,630
| +450% | +$2.72M | ﹤0.01% | 2172 |
|
|
2018
Q4 | $507K | Sell |
186,851
-141,251
| -43% | -$465K | ﹤0.01% | 3313 |
|
|
2018
Q3 | $1.1M | Buy |
328,102
+51,896
| +19% | +$160K | ﹤0.01% | 3261 |
|
|
2018
Q2 | $712K | Buy |
276,206
+89,367
| +48% | +$222K | ﹤0.01% | 3641 |
|
|
2018
Q1 | $410K | Sell |
186,839
-133,104
| -42% | -$300K | ﹤0.01% | 3820 |
|
|
2017
Q4 | $635K | Sell |
319,943
-419,665
| -57% | -$913K | ﹤0.01% | 3481 |
|
|
2017
Q3 | $2.4M | Sell |
739,608
-265,019
| -26% | -$818K | ﹤0.01% | 2415 |
|
|
2017
Q2 | $3.23M | Buy |
1,004,627
+866,168
| +626% | +$2.45M | ﹤0.01% | 2227 |
|
|
2017
Q1 | $393K | Buy |
+138,459
| New | +$333K | ﹤0.01% | 3217 |
|
|
2016
Q3 | – | Sell |
-230,825
| Closed | -$242K | – | 5306 |
|
|
2016
Q2 | $242K | Buy |
230,825
+61,848
| +37% | +$59.8K | ﹤0.01% | 3671 |
|
|
2016
Q1 | $146K | Sell |
168,977
-23,369
| -12% | -$22.6K | ﹤0.01% | 3800 |
|
|
2015
Q4 | $231K | Buy |
192,346
+96,580
| +101% | +$134K | ﹤0.01% | 3655 |
|
|
2015
Q3 | $162K | Buy |
95,766
+8,581
| +10% | +$16.8K | ﹤0.01% | 3891 |
|
|
2015
Q2 | $181K | Buy |
87,185
+37,162
| +74% | +$90.1K | ﹤0.01% | 3940 |
|
|
2015
Q1 | $135K | Sell |
50,023
-35,409
| -41% | -$89.8K | ﹤0.01% | 4001 |
|
|
2014
Q4 | $219K | Sell |
85,432
-20,905
| -20% | -$47K | ﹤0.01% | 4252 |
|
|
2014
Q3 | $192K | Buy |
106,337
+34,695
| +48% | +$75.6K | ﹤0.01% | 4090 |
|
|
2014
Q2 | $190K | Sell |
71,642
-12,075
| -14% | -$36.3K | ﹤0.01% | 4157 |
|
|
2014
Q1 | $292K | Buy |
83,717
+31,255
| +60% | +$139K | ﹤0.01% | 3680 |
|
|
2013
Q4 | $234K | Sell |
52,462
-114,440
| -69% | -$466K | ﹤0.01% | 3611 |
|
|
2013
Q3 | $677K | Buy |
166,902
+70,009
| +72% | +$306K | ﹤0.01% | 3268 |
|
|
2013
Q2 | $402K | Buy |
+96,893
| New | +$374K | ﹤0.01% | 3311 |
|
Other funds holding ATRS
Deutsche Bank's ATRS Position: Q2 2022 in Review
Deutsche Bank sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 154,063 shares — an estimated $632K sold.
Deutsche Bank first reported a position in ATRS in Q2 2013 and held it in 34 quarters. The position peaked at $3.79M in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Deutsche Bank reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Deutsche Bank sold 154,063 Antares Pharma, Inc. shares in Q2 2022, an estimated $632K.
- Deutsche Bank first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 34 quarters.
- Deutsche Bank's Antares Pharma, Inc. position peaked at $3.79M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.